About Medilloyd Medicament Private Limited
Data last updated: 22 July 2025
Medilloyd Medicament Private Limited is a private limited company based in Cuttack, Orissa, India. The company is currently undergoing Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency professional. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 20 April 2012, the company has been in operation for over 14 years.
Registered with ROC Cuttack under CIN U24230OR2012PTC015269.
Capital: an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors Subhalaxmi Jena and Shiba Prasanna Jena.
Last AGM: 31 December 2020. Financial statements filed for year ended 31 March 2020. Office: Side Lane Of Sbi Hyderabad Kanika Chhak Tulsipur, Cuttack, Orissa, India – 753008.
As per the financials filed for FY 2020, the company reported a revenue of ₹9.88 Cr, a growth of 11% compared to the previous year.
As per MCA filings, the company has open charges of ₹6.85 Cr and satisfied charges of ₹2.7 Cr on record.
The company is undergoing Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency professional, and the company may not be able to independently enter into new commitments. The last known website on record is medilloydmedicament.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered AddressSide Lane Of Sbi Hyderabad Kanika Chhak Tulsipur, Cuttack, Orissa, India – 753008
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Business Activity of Medilloyd Medicament Private Limited
Medilloyd Medicament Private Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details for Medilloyd Medicament Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Medilloyd Medicament Private Limited
Medilloyd Medicament Private Limited is audited by H K CHANDAK & CO for the financial year 2020. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| H K CHANDAK & CO | Locked | Locked | Locked |
Complete auditor history for Medilloyd Medicament Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Medilloyd Medicament Private Limited
Medilloyd Medicament Private Limited is currently managed by 2 directors, with 1 former director having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Subhalaxmi Jena
Also directs:
Oppurtune Ventures Private Limited
|
Director | 20 Apr 2012 | 14 Years 3 Months | As last reported |
|
Shiba Prasanna Jena
Also directs:
Oppurtune Ventures Private Limited
|
Managing Director | 20 Apr 2012 | 14 Years 3 Months | As last reported |
Financials of Medilloyd Medicament Private Limited FY 2020 filings available
Medilloyd Medicament Private Limited reported revenue of ₹9.88 Cr (up 11.00% YoY) for FY 2020.
Ten-year financial statements for Medilloyd Medicament Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Medilloyd Medicament Private Limited
Shareholding and ownership data for Medilloyd Medicament Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Medilloyd Medicament Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Mar 2017 | Others | ₹4.1 Cr | Open |
| 24 Sep 2015 | Dcb Bank Limited | ₹2.75 Cr | Open |
| 24 Feb 2014 | Canara Bank | ₹2.7 Cr | Satisfied |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Medilloyd Medicament Private Limited
View historical data on people associated with Medilloyd Medicament Private Limited, including employment history and EPFO contributions.
Employee and EPFO history for Medilloyd Medicament Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Medilloyd Medicament Private Limited
GST registrations and filing compliance for Medilloyd Medicament Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Medilloyd Medicament Private Limited
Credit ratings, litigation, and regulatory alerts for Medilloyd Medicament Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Medilloyd Medicament Private Limited
MSME payment history for Medilloyd Medicament Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Medilloyd Medicament Private Limited
Corporate group structure for Medilloyd Medicament Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Medilloyd Medicament Private Limited
MCA filings and documents for Medilloyd Medicament Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Medilloyd Medicament Private Limited
Frequently Asked Questions about Medilloyd Medicament Private Limited
Medilloyd Medicament Private Limited is undergoing "Corporate Insolvency Resolution Process" (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency resolution professional. The company may not be able to independently enter into new commitments during this period. This is a high-risk status - verify the resolution status before any engagement.
Medilloyd Medicament Private Limited is a company under insolvency, formerly operating as a private limited company in the pharma sector based in Cuttack, Orissa, India. It was incorporated on 20 April 2012 and is registered under CIN U24230OR2012PTC015269. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Medilloyd Medicament Private Limited reported revenue of ₹9.88 Cr for FY 2020 (up 11.00% YoY).
The current directors of Medilloyd Medicament Private Limited are:
- Subhalaxmi Jena - Director
- Shiba Prasanna Jena - Managing Director
The CIN (Corporate Identification Number) of Medilloyd Medicament Private Limited is U24230OR2012PTC015269. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medilloyd Medicament Private Limited has open charges of ₹6.85 Cr and satisfied charges of ₹2.7 Cr as per latest MCA filings.